Quanterix (QTRX) Non-Current Deffered Revenue (2017 - 2026)
Quanterix's (QTRX) quarterly Non-Current Deffered Revenue came in at $2.8 million in Q1 2026, up 154.55% YoY from $1.1 million in Q1 2025, and down 52.06% on a QoQ basis from $5.8 million in Q4 2025.
Quanterix (QTRX) Non-Current Deffered Revenue (2017 - 2026) Analysis & Trends
Quanterix (QTRX) has 10 years of Non-Current Deffered Revenue data on file, last reported at $2.8 million in Q1 2026.
- Quarterly Non-Current Deffered Revenue rose 154.55% year-over-year to $2.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.8 million (up 154.55% YoY) and the FY2025 annual result came in at $5.8 million, up 443.34% from the prior year.
- Non-Current Deffered Revenue retreated to $2.8 million in Q1 2026, from $5.8 million in the prior quarter.
- In the past five years, Non-Current Deffered Revenue ranged from a high of $7.3 million in Q3 2025 to a low of $884000.0 in Q3 2024.
- A 5-year average of $1.9 million and a median of $1.2 million in 2023 frame the typical range for Non-Current Deffered Revenue.
- Annual changes were most pronounced in 2024 — Non-Current Deffered Revenue slumped 34.25% — and 2025, when it jumped 730.43%.
- Tracing QTRX's Non-Current Deffered Revenue over 5 years: stood at $1.4 million in 2022, then dropped by 13.29% to $1.2 million in 2023, then decreased by 12.55% to $1.1 million in 2024, then surged by 443.34% to $5.8 million in 2025, then plunged by 52.06% to $2.8 million in 2026.
- The last three Non-Current Deffered Revenue figures came in at $2.8 million (Q1 2026), $5.8 million (Q4 2025), and $7.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | - |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | - |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | - |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 539.34 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | - |
| 10 | Quanterix | 141.97 Mn | 48.44 Mn | 12.67 Mn | 2.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.50 Mn |
| Mar 31, 2026 | 2.80 Mn |
| Dec 31, 2025 | 5.83 Mn |
| Sep 30, 2025 | 7.34 Mn |
| Jun 30, 2025 | 1.06 Mn |
| Mar 31, 2025 | 1.10 Mn |
| Dec 31, 2024 | 1.07 Mn |
| Sep 30, 2024 | 884,000.00 |
| Jun 30, 2024 | 928,000.00 |
| Mar 31, 2024 | 933,000.00 |
| Dec 31, 2023 | 1.23 Mn |
| Sep 30, 2023 | 1.13 Mn |
| Jun 30, 2023 | 1.30 Mn |
| Mar 31, 2023 | 1.42 Mn |
| Dec 31, 2022 | 1.42 Mn |
| Sep 30, 2022 | 1.59 Mn |
| Jun 30, 2022 | 1.53 Mn |
| Mar 31, 2022 | 1.22 Mn |
| Dec 31, 2021 | 1.10 Mn |
| Sep 30, 2021 | 929,000.00 |